EUVIMEDEUVIMED entdecken
Crossref

Interpreting Outcomes of Intrathecal Therapy for Tuberculous Meningitis: Treatment Timing, Patient Selection, and Residual Uncertainty

Rui Chen iD, Feng Li

Clinical Infectious Diseases · 07.10.2026

DOI: 10.1093/cid/ciag637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 07.10.2026. Verfasst von Rui Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China. Die Arbeit nennt 3 Literaturangaben. Gefördert von: National Science and Technology Major Project, Shanghai Hospital Development Center.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
  • Department of Pulmonary and Critical Care Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Tuberculosis Research Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

ORCID-Profile: Rui Chen

Förderung

  • National Science and Technology Major Project
  • Shanghai Hospital Development Center

Zitieren

APA

Chen, R., & Li, F. (2026). Interpreting Outcomes of Intrathecal Therapy for Tuberculous Meningitis: Treatment Timing, Patient Selection, and Residual Uncertainty. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag637

Vancouver

Chen R, Li F. Interpreting Outcomes of Intrathecal Therapy for Tuberculous Meningitis: Treatment Timing, Patient Selection, and Residual Uncertainty. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag637

BibTeX
@article{Chen2026,
  author = {Chen, Rui and Li, Feng},
  title = {Interpreting Outcomes of Intrathecal Therapy for Tuberculous Meningitis: Treatment Timing, Patient Selection, and Residual Uncertainty},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag637}
}
Kostenlos starten →